DURHAM, N.C.---- Codetta Bio , the life sciences company developing advanced multi-omic biomarker measurement tools, announced today that Jacques Corriveau has been appointed as its new Chief Executive Officer. In this role, Corriveau will lead Codetta’s next phase of commercial growth as the team advances the development of its disruptive multi-omic solution and brings its technology to market. Dr. Anthony Lemmo, who served as Codetta’s CEO for the last year, will continue to support the development and commercialization of the company’s breakthrough multi-omic biomarker measurement technology as Chief Technology Officer.